D. Valleurmasson et al., BRONCHOPULMONARY DYSPLASIA - OUTCOME AT 2 YEARS OF AGE OF 88 CHILDRENBORN BETWEEN 1984 AND 1988, Archives francaises de pediatrie, 50(7), 1993, pp. 553-559
Background. The survival and outcome of infants with bronchopulmonary
dysplasia (BD) depend on the patient's maturity, the severity of the B
D and nutritional problems. This study evaluates the specific role of
chronic pulmonary failure in the growth and development of infants rec
overing from BD. Population and methods. 88 infants admitted for BD fr
om January 1984 to December 1988, having gestational age from 25 to 41
weeks 5 days (mean : 29) and birth weight from 680 to 3 400 g (mean :
1,195) were studied. All infants were given respiratory support for 6
to 914 days (mean 84) and oxygen therapy for 28 to 1,232 days (mean :
119). 29 infants were given corticosteroids for more than 1 month. Th
e outcome of the 80 infants with gestational ages of less than 33 week
s was compared to that of 272 infants with the same gestational age bu
t not suffering from BD on their 28th day. The infants in both groups
were examined at 2 years of age and classified as: a) handicapped (neu
rologic deficit, IQ <80, hearing loss, blindness, convulsions), b) dou
btful (transitory neurology dysfunction), c) normal. Results. Of the 8
8 infants still living at the age of 28 days, 19 died before the age o
f 2 years : 16 of the 64 surviving infants who could be followed until
the age of 2 years were classified as handicapped, 13 were considered
doubtful and 35 were normal. The more significant risk factors for ne
urodevelopmental impairment were: a) the presence of porencephaly and/
or ventricular dilatation on brain ultrasonography, b) head circumfere
nce <- 2 SD at the end of hospital stay, c) oxygen therapy and hospita
lization >5-6 months. The group of infants with BD had a higher death
rate (24 % vs 3.7 in the group without BD) and more frequent neurodeve
lopmental impairment at gestational ages of >31-32 weeks. Conclusions.
BD is an extra risk for the survival and neurodevelopment of infants
with gestational age >31 weeks.